A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)-Reference-Cited by-同舟云学术

A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Published:2007-07-05 Issue:9 Volume:21 Page:1945-1951
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Al-Ali H K,Brand R,van Biezen A,Finke J,Boogaerts M,Fauser A A,Egeler M,Cahn J-Y,Arnold R,Biersack H,Niederwieser D,de Witte T

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404774.pdf

Reference51 articles.

1. Bennett JM, Catovsky D, Daniel MD, Flandrin G, Galton DAG, Gralnick HR, et al., FAB Co-operative Group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199.

2. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes. Blood 1989; 74: 395–408.

3. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.

4. Aul C, Gattermann N, Schneider W . Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 1992; 82: 358–367.

5. Armitage JO, Dick FR, Needlemann SW, Burns CP . Effect of chemotherapy for the dysmyelopoietic syndrome. Cancer Treat Rep 1981; 65: 601–605.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature;Bone Marrow Transplantation;2023-04-25

2. Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2019-06

3. Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2017-07

4. 5q− syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10);International Journal of Hematology;2016-12-02

5. Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT;Journal of Hematology & Oncology;2016-09-02